Alteration of xenobiotic metabolizing enzymes by resveratrol in liver and lung of CD1 mice
Introduction
A large number of natural products are under scrutiny for their therapeutic potential, both in terms of disease prevention and treatment. A remarkable representative of this group of compounds is resveratrol (RSV, 3,4′,5-trihydroxystilbene). RSV is a polyphenolic compound synthesized by a wide variety of plant species, including grapes, and is present in red wine (Pervaiz, 2003). The relatively high concentration of RSV in wine (Siemann and Creasy, 1992), and its documented cardio-protective effect (Sato et al., 2002), formed the basis for the so-called “French paradox” (Kopp, 1998). Subsequently, a large number of in vitro and in vivo studies identified multiple beneficial effects for this compound (Fremont, 2000).
Most of the initial work on RSV was centred on its effects on metabolic pathways regulating cardiovascular biology, such as lipid metabolism and platelet function, atherosclerosis, arthritis or autoimmune disorders. Jang et al. (1997) documented the ability of RSV, in vitro, to inhibit the carcinogenic process at multiple stages. Consequently, several in vivo studies showed that the systemic administration of RSV was associated with inhibition of the initiation and growth of many tumours including breast, prostate, colon, lung, esophagus, liver, non-melanoma skin cancer, leukemia, neuroblastoma and fibrosarcoma, in a wide variety of rodent cancer models (Athar et al., 2007). The efficacy of low doses, for example 200 μg/kg b.w. daily in a rat model of colon carcinogenesis, suggested that the concentration of RSV in dietary sources, such as red wine, could be therapeutic in some cases (Tessitore et al., 2000). At higher, but pharmacologically acceptable doses, the protective effects of RSV were frequently observed. For example, a daily dose of 40 mg/kg b.w. RSV increased the survival of mice with subcutaneous neuroblastomas from 0% to 70% (Chen et al., 2004).
Since the discovery of the cancer chemopreventive properties of RSV in animal models, many investigators directed their attention to understanding the molecular mechanisms underlying its observed biological effects. These included the suppression of cellular proliferation via inhibition of key steps in the signal transduction pathways (Mgbonyebi et al., 1998, Haworth and Avkiran, 2001, Tou and Urbizo, 2001, Pozo-Guisado et al., 2002) and cyclin-dependent kinases (cdks) (Ragione et al., 1998), promotion of cellular differentiation (Mizutani et al., 1998), scavenging/suppression of intracellular reactive oxygen intermediates (ROI) (Manna et al., 2000, Lee and Lee, 2006), induction of apoptotic cell death, both by directly triggering apoptosis-promoting signalling cascades, and by blocking antiapoptotic mechanisms (Fulda and Debatim, 2006, Clement et al., 1998, Huang et al., 1999, Hsieh and Wu, 1999), anti-inflammatory activity via down-regulation of proinflammatory cytokines (Rotondo et al., 1998, Wadsworth and Koop, 1999) and inhibition of androgen receptor function and estrogenic activity (Lu and Serrero, 1999, Mitchell et al., 1999).
Although most in vivo studies seem to support a chemopreventive effect of RSV, there are notable exceptions in which no benefit has been observed. For example, despite promising in vitro results, i.p. administration of 1–5 mg/kg b.w. RSV daily for 23 consecutive days failed to affect the growth or metastasis of breast cancer in mice (Bove et al., 2002). In two 8-weeks-long rat feeding experiments, with 50 and 300 mg/kg b.w. of RSV, no cancer-preventive effects were seen, which was explained to be probably due to the formation of various RSV conjugates which reduced its bioavailability (Wenzel et al., 2005). In N-nitroso-bis(2-oxopropyl)amine treated hamsters, 10 ppm RSV supplemented diet for three weeks failed to reduce pancreatic cancer lesions (Kuroiwa et al., 2006). RSV consumed ad libitum in the diet at doses of 4, 20 or 90 mg/kg b.w., did not modify tumorigenesis in Apc(Min/+) mice (Ziegler et al., 2004). Short RSV treatment (10–100 mg/kg b.w.) of prepubertal female rats affected endocrine functions and, especially, accelerated MNU-induced mammary carcinoma development (Sato et al., 2003). In addition, a recent study indicated that RSV was not likely to be useful in melanoma treatment in athymic mice (Niles et al., 2006).
Xenobiotic metabolizing enzyme (XME) modulation by phytochemicals is believed to be one of the most promising chemopreventive strategies (Talalay, 2000). A substantial body of evidence supports the concept that compounds able to inhibit Phase-I “bioactivating” enzymes and/or induce the Phase-II “detoxifying” enzymes may reduce the formation of reactive intermediates able to interact with DNA, thus lowering the production of genotoxins. In this context, with the aim to evaluate whether the chemopreventive activity of RSV stems from XME modulation, and to better define its metabolic/toxicological profile, the effects of RSV supplementation on microsomal Phase-I and Phase-II murine metabolism were investigated in different tissues of CD1 mice. The potential effect of XME manipulation by RSV in the field of cancer chemoprevention is discussed.
Section snippets
Chemicals
Nicotinamide adenine dinucleotide phosphate, oxidized and reduced form (NADP+ and NADPH), 7-ethoxyresorufin, p-nitrophenol, aminopyrine, ethoxycoumarin, 16α-hydroxytestosterone, corticosterone, testosterone, androsten-4-ene-3,17-dione and RSV were purchased from Sigma Chemical Co. (St. Louis, MO, USA); glucose 6-phosphate, glucose 6-phosphate dehydrogenase and cytochrome c were from Boehringer-Mannheim (Germany); pentoxyresorufin and methoxyresorufin were from Molecular Probes (Eugene, OR,
Effects of RSV supplementation on body weight
RSV did not significantly affect absolute or relative murine liver and lung weights (data not shown).
Effects of RSV supplementation on hepatic Phase-I XMEs, single probe
Table 1 shows the CYP content, CYP-reduced activity, and various microsomal mixed function monooxygenases (MFO) in the liver of male Swiss Albino CD1 mice, after 25 or 50 mg/Kg b.w. RSV administration (for one day or daily for seven consecutive days). In all animals, the microsomal electron transport chain components were significantly inactivated with CYP level reduced by ∼25% (p < 0.01) with the
Discussion
The ability to inhibit the “activating” Phase-I metabolizing enzymes and/or induce the Phase-II “detoxifying” enzymes is one of the most highly-regarded properties of an effective chemopreventive agent. The assumption is that the inhibition of Phase-I enzymes and induction of Phase-II enzymes may ultimately lead to reduced formation of reactive metabolites and presumably would result in reduced cancer incidence (Morse and Stoner, 1993). According to this belief, RSV is regarded as a highly
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Acknowledgement
This work was supported by RFO (Ricerca Fondamentale Orientata) grant.
References (80)
- et al.
DNA breakage by resveratrol and Cu(II): reaction mechanism and bacteriophage inactivation
Cancer Lett.
(2000) A simple and sensitive assay of 7-ethoxycoumarin demethylation
Anal. Biochem.
(1978)- et al.
Resveratrol: a review of preclinical studies for human cancer prevention
Toxicol. Appl. Pharmacol.
(2007) - et al.
Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo
Biochem. Biophys. Res. Commun.
(2002) - et al.
Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologueses: a series of substrates to distinguish between different induced cytochrome P450
Biochem. Pharmacol.
(1985) - et al.
Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury
Eur. J. Pharmacol.
(2004) - et al.
Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4
Life Sci.
(2000) - et al.
Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice
Surgery
(2004) - et al.
Oxidation of caffeine to theobromine and theophillyne is catalysed primarily by flavin-containing monooxygenase in liver microsomes
Biochem. Biophys. Res. Commun.
(1997) - et al.
Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells
Blood
(1998)
Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity
Life Sci.
Biological effects of resveratrol
Life Sci.
Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review
Cancer Detect. Prev.
Glutathione S-transferases. The first enzymatic step in mercapturic acid formation
J. Biol. Chem.
Inhibition of protein kinase D by resveratrol
Biochem. Pharmacol.
Toxicogenomics of resveratrol in rat liver
Life Sci.
Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines
Exp. Cell Res.
Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
Carcinogenesis
Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor
J. Mol. Cell Cardiol.
Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters
Cancer Lett.
Protein measurement with Folin phenol reagent
J. Biol. Chem.
A sensitive kinetic assay for UDP-glucuronosyl transferase using 1-naphthol as substrate
Anal. Biochem.
Resveratrol, a naturally occurring polyphenol, induces sister chromatid exchanges in a Chinese hamster lung (CHL) cell line
Mut. Res.
The 4′-hydroxy group is responsible for the in vitro cytogenetic activity of resveratrol
Mut. Res.
Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3–E1 cells
Biochem. Biophys. Res. Commun.
Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth
J. Nutr.
The carbon monoxide-binding pigment of liver microsomes I. Evidences for its hemoprotein nature
J. Biol. Chem.
Diet and risk of cancer
Lancet
Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components
Toxicol. Lett.
The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle
Biochem. Pharmacol.
Resveratrol arrests the cell division cycle at S/G2 phase transition
Biochem. Biophys. Res. Commun.
Prepubertal resveratrol exposure accelerates N-methyl-N-nitrosourea-induced mammary carcinoma in female Sprague-Dawley rats
Cancer Lett.
Hormonal and genotoxic activity of resveratrol
Toxicol. Lett.
Resveratrol inhibits the formation of phosphatidic acid and diglyceride in chemotactic peptide- or phorbol ester-stimulated human neutrophils
Cell. Signal.
Assay of hepatic microsomal testosterone hydroxylases by high-performance liquid chromatography
Anal. Biochem.
Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages
Biochem. Pharmacol.
Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Min/+) mice
J. Nutr.
Techniques in Protein Chemistry
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients
J. Natl. Cancer Inst.
Stability of microsomal monooxygenases in murine liver S9 fractions derived from phenobarbital and β-naphthoflavone induced animals under various long-term conditions of storage
Teratogen. Carcin. Mut.
Cited by (34)
Preclinical studies on melanogenesis proteins using a resveratrol-nanoformula as a skin whitener
2022, International Journal of Biological MacromoleculesCitation Excerpt :The activity of another antioxidant enzyme activity, catalase, did not change whereas glutathione S-transferase (GST) was significantly inhibited in both BNF and F1-treated groups [Table 4]. Supporting our finding, it has been found that a low dose of T-RES significantly inhibited GST activity in mice lungs [62]. Also, liver markers activities including LDH and AST were significantly decreased in BNF and F1-treated groups (Table 4).
Novel mechanisms underlying bioactivities of polyphenols via hormesis
2022, Current Opinion in ToxicologyHarmful effects behind the daily supplementation of a fixed vegetarian blend in the rat model
2016, Food and Chemical ToxicologyCitation Excerpt :UDP-glucuronosyl transferase (UPDGT) was determined kinetically using 1-naphthol as substrate, monitoring 1-naphtholglucuronide production fluorimetrically. Details of methods have been reported (Canistro et al., 2009). Testosterone hydroxylase (TH) was determined by separating the hydroxylated metabolites using a Waters 1525 high-performance liquid chromatography apparatus equipped with a Supelco LC-18 column (250 × 4.6 mm) as previously reported (Paolini et al., 1997).
Cytoprotective Role of Dietary Phytochemicals Against Cancer Development via Induction of Phase II and Antioxidant Enzymes
2016, Advances in Molecular ToxicologyCitation Excerpt :In other experimental work, treatment of mice with resveratrol resulted in substantial inhibition of GST with concomitant induction of UDP-glucuronosyl transferase (UGT) [109]. In overall assessment, it was reported that this effect is dependent on dose, duration, and route of administration of resveratrol [109]. To this end, it appears that the stimulating or suppressing activity of the cytoprotective enzymes by resveratrol is tissue and cell type specific and also is associated with specific isoforms of the enzymes.
Black cabbage seed extract affects rat Cyp-mediated biotransformation: Organ and sex related differences
2012, Food and Chemical Toxicology